TINCY OOMMEN: Open Payments
NPI 1891295069 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,256 in 133 payments from 21 companies in 2025. Trend: 2023 $1,518 · 2024 $1,742 · 2025 $2,256
Food & beverage: $2,152Education: $104
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $464 |
| Janssen Biotech, Inc. | 13 | $328 |
| Galderma Laboratories, L.P. | 16 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $199 |
| Regeneron Healthcare Solutions, Inc. | 13 | $166 |
| ABBVIE INC. | 10 | $148 |
| Incyte Corporation | 14 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $116 |
| Botanix SB Inc | 4 | $72 |
| LEO Pharma Inc. | 3 | $66 |
Products named: Zoryve, TREMFYA, NEMLUVIO, DUPIXENT, OPZELURA, ILUMYA, SKYRIZI, SOFDRA.
Industry payments across IL — which companies pay providers there.
